Laylay, Wilfredo D.

HRN: 16-14-51  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2026
CEFTRIAXONE 1G (VIAL)
03/04/2026
03/11/2026
IV
2g
OD
Decompensated Liver Disease; Massive Ascites
Checking Initial Appropriateness 
03/05/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/05/2026
03/12/2026
IV
4.5g
Q8H
Intra Abdominal
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: